Brain Tumor
RSSArticles
-
New Diagnostic Methods for Creutzfeldt-Jakob Disease
Synopsis: Novel noninvasive diagnostic tests for Creutzfeldt-Jakob disease (CJD; nasal brushings) and variant CJD (urinary prion proteins) are reported to be highly sensitive and specific in two recent studies.
-
Will New Approaches Help to Treat ALS?
-
Pharmacology Watch: High-Dose Rofecoxib Confirmed Prothrombotic, Study Shows
Debate over the cardiovascular effects of COX-2 inhibitors has raged for more than a year since a special communication was published in JAMA last August suggesting an increase in cardiovascular events with rofecoxib (Vioxx). Now a large retrospect, the cohort study from the Tennessee Medicaid program seems to confirm the prothrombotic effects of rofecoxib, at least in high dose. -
Pharmacology Watch: Forgot Your Ginkgo? Forget About It, Study Shows
-
Antipsychotics in Alzheimer's Patients: The CATIE-AD Study
Because of adverse effects, special care should be used when prescribing the atypical antipsychotic drugs for patients with dementia. -
Rolandic Epilepsy Surgery — Weighing the Risks
Surgery for epilepsy in and around sensory-motor cortex can be effective in controlling seizures, but mild post-operative neurological deficits are not uncommon in patients operated on after age 25. -
What is the Mechanism of Transient Global Amnesia?
Patients show reversible MRI signal abnormalities in the CA-1 sector of the hippocampal cornu ammonis early in the course of TGA. They are not correlated with any specific clinical or memory features of the episode. -
Pharmacology Watch
Patients with coronary artery disease who have received intra-coronary, drug-eluding stents (DES) may benefit from longer courses of clopidogrel than is currently standard. -
Clinical Briefs in Primary Care Supplement
-
Sentinel Headaches: Do they Predict Rebleeding after Subarachnoid Hemorrhage?
Patients with sentinel headaches occurring in the 4-week period prior to a subarachnoid hemorrhage have a 10-fold increase in early rebleeding. These patients may benefit from ultra-early treatment including aneurysm obliteration.